Local Therapy for ER/PR-positive Oligometastatic Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Local Therapy for ER/PR-positive Oligometastatic Breast Cancer — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Brazil

ICESP, São Paulo, São Paulo

Key details

Phase

Safety & dosing

Sponsor

Instituto do Cancer do Estado de São Paulo

Enrollment target

~74 participants

Started

April 2021

Primary completion

April 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Female only

Last updated August 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.